¿ì¸®³ª¶ó ½ÇÁ¤¿¡ ¸Â´Â ´ç´¢º´È¯ÀÚÀÇ °ü¸®¸¦ À§ÇÏ¿© °´°üÀûÀÎ ±Ù°Å¿¡ ±â¹ÝÇÏ¿© Á¦ÀÛµÈ “2019 ´ç´¢º´ Áø·áÁöħ(Á¦6ÆÇ)”ÀÌ ¹ß°£µÇ¾ú½À´Ï´Ù.
¼ÒÃ¥ÀÚ´Â Áø·áÁöħ ±Ç°í¾È°ú ºÎ·ÏÀÌ ½Ç·Á ÀÖÀ¸¸ç, ºÎ·Ï¿¡´Â ±¹³»¿¡¼ »ç¿ë °¡´ÉÇÑ ¸ðµç Á¾·ùÀÇ ´ç´¢º´¾àÁ¦ (°æ±¸¾àÁ¦ ¹× GLP-1 ¼ö¿ëüÀÛ¿ëÁ¦, Àν¶¸° µî)¿¡ ´ëÇÑ »ó¼¼Á¤º¸¿Í ´ç´¢º´¾àÁ¦ º¸Çè±âÁرîÁö Áø·áÇöÀå¿¡¼ ½±°Ô »ç¿ëÇÒ ¼ö ÀÖ´Â ½ÇÁúÀûÀÎ ³»¿ëÀÌ ´ã°ÜÀÖ½À´Ï´Ù.
Ãâó : ´ëÇÑ´ç´¢º´ÇÐȸ http://www.diabetes.or.kr/pro/publish/guide.php?code=guide&number=768&mode=view